This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy, Journal of Clinical and Experimental Hematopathology, January 2024, Japanese Society for Lymphoreticular Tissue Research,
DOI: 10.3960/jslrt.24009.
You can read the full text:
The following have contributed to this page
